Building the Business Case for Complex Care
In this session, you will hear how Regional One Health has created a successful complex CAE program, focused on uninsured medically and socially complex patients, who are high cost, high need. You'll also see how they have demonstrated improved outcomes from cost, utilization, quality, and satisfaction perspectives which have made a positive impact to the financial position of the organization.
Predictive analytics for real time cost manangement
Learn how Texas Health Resources made the leap to real-time management of costs using a financial decision support platform, augment with visualizations and integration of third-party data. During this session, attendees will gain understanding of how to best utilize data to identify real-time opportunities to manage and save cost.
It Takes a Community: Understanding Cost with the L7 Model
Standard cost accounting using ratios of cost to charges (RCC) offers minimal value. In this session, you'll explore the framework for assessing your current cost accounting methodology, understanding the accuracy of your cost data, and benchmarking against peers with the HFMA-Strata L7 Cost Accounting Adoption Model. Panelists from provider organizations will review their organizations' experience accessing accurate cost data by using advanced cost accounting, as measured by the L7 model.
How do Hospitals Respond to Private Equity Physician Deals?
While hospitals have a myriad competition for affiliation transactions with direct hospital and even larger group competitors, the advent of private equity deals has created another formidable challenge. This session not only presents the PE model with real world examples, it offers an alternative explanation of a "PE-like" model for hospitals. The session will provide practical examples of how hospitals may counteract and respond to PE transactions by not only providing alternative and analogous structures, but by also considering legal and regulatory issues. The attendees will afterward possess definitive strategies with legally sanitized parameters to compete with PE deals.